Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EPS (Basic): 2014-2024

Historic EPS (Basic) for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $2.14.

  • Collegium Pharmaceutical's EPS (Basic) rose 244.83% to $1 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.85, marking a year-over-year decrease of 32.48%. This contributed to the annual value of $2.14 for FY2024, which is 49.65% up from last year.
  • As of FY2024, Collegium Pharmaceutical's EPS (Basic) stood at $2.14, which was up 49.65% from $1.43 recorded in FY2023.
  • Collegium Pharmaceutical's EPS (Basic)'s 5-year high stood at $2.14 during FY2024, with a 5-year trough of -$0.74 in FY2022.
  • In the last 3 years, Collegium Pharmaceutical's EPS (Basic) had a median value of $1.43 in 2023 and averaged $0.94.
  • In the last 5 years, Collegium Pharmaceutical's EPS (Basic) plummeted by 136.10% in 2022 and then skyrocketed by 293.24% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's EPS (Basic) (Yearly) stood at $0.78 in 2020, then skyrocketed by 162.82% to $2.05 in 2021, then crashed by 136.10% to -$0.74 in 2022, then surged by 293.24% to $1.43 in 2023, then soared by 49.65% to $2.14 in 2024.